References
- ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002CA Cancer J Clin20055527410815761078
- TangZYYeSLLiuYKA decade’s studies on metastasis of hepatocellular carcinomaJ Cancer Res Clin Oncol2004130418719614685850
- MitsunobuMToyosakaAOriyamaTOkamotoENakaoNIntrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vesselClin Exp Metastasis19961465205298970582
- WuMCChenHZhangXHYaoXPYangJMSurgical treatment of primary liver cancer: 1102 casesAcad J Sec Mil Med Univ1993143201204
- BelghitiJHiramatsuKBenoistSMassaultPSauvanetAFargesOSeven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resectionJ Am Coll Surg20001911384610898182
- ZiserAPlevakDJWeisnerRHRakelaJOffordKPBrownDLMorbidity and mortality in cirrhotic patients undergoing anesthesia and surgeryAnesthesiology199990142539915311
- CalneRYamanoiAOuraSKawamuraMLiver transplantation for hepatocarcinomaSurg Today1993231138384905
- TangZYThe meaning and approach to carry out liver metastasis and recurrence researchChin J Gen Surg20062111761
- ThomasMBZhuAXHepatocellular carcinoma: The need for progressJ Clin Oncol200523132892289915860847
- WuMCSurgical treatment of primary liver cancerChin J Gen Surg20093413
- QinJMXuXJShengXThe effect of brucine on hepatocellular carcinoma cell lines in vitroChin J Gen Surg2011263219221
- DengXKCaiBCLvXYAnti-tumor effects comparision of the brucine and its liposomes in transplanted tumor-bearing miceJ Herb Med2006373389393
- DengXKCaiBCYinWZhangXCLiWDSunQBrucine on mouse tumor inhibitionChin J Nat Med200536392396
- DengXKCaiBCYinWLiuTSSunQLiWDResearch of the anti-tumor effect and toxicity of brucine in Heps tumor-bearing miceChin Pharmacol Bulletin20062213539
- QinJMZhangYDWangHYWuMCNanotechnologies in the diagnosis and treatment of liver diseaseChin J Hepatobiliary Surg2004109646648
- WangYLiQFengNPTanshinone IIA nanoparticles in the treatment of mouse liver cancer and its effects on Cyclin E expressionShanghai Traditional Chin Med2007417477
- TorchilinVPDrug targetingEur J Pharm Sci200011Suppl 2S819111033430
- DavdaJLabhasetwarVCharacterization of nanoparticle uptake by endothelial cellsInt J Pharm20022331–2515911897410
- SahooSKPanyamJPrabhaSLabhasetwarVResidual polyvinylalcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptakeJ Control Release200282110511412106981
- PanyamJLabhasetwarVDynamics of endocytosis and exocytosis of poly (D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cellsPharm Res200320221222012636159
- LynchIAre there generic mechanisms governing interactions between nanoparticles and cells? Epitope mapping the other layer of the protein– material interfacePhysica A20073733511520
- RowlandRESTaylorPWFlorenceATAttachment, uptake and transport of nanoparticles coated with an internal in A fragment in Caco-2 cell monolayerJ Drug Deliv Sci Technol2005153313317
- WuJNantzMHZernMATargeting hepatocytes for drug and gene delivery: emerging novel approaches and applicationsFrontiers in Bioscience200271717725
- LiuXBCaiMYPreparation and immunological identification of nanoparticles against human hepatocellular carcinoma in vitroChin J Immunology2000165262265
- ChenYTangRHuangWStudy of hepatoma-specific immunal phospholipids doxorubicin nanoparticlesChin Pharmacist2002512712714
- HuKQKyuloNLLimNElhazinBHillebrandDJBockTClinical significance of elevated alpha fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinomaAm J Gastroenterol200499586086515128351
- MontaserLMAbbasOMSaltahAMWakedIACirculating AFP mRNA as a possible indicator of hematogenous spread of HCC cells: a possible association with HBV infectionJ Egypt Natl Canc Inst2007191486018839035
- KamiyamaTTakahashiMNakagawaTAFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinomaAnn Surg2006244345146316926571
- van der HeidenPLJedemaIWillemzeRBargeRMEfficacy and toxicity of gemtuzumab ozogamicin in patients with acute myeloid leukemiaEur J Haematol200676540941316480432
- AdamsGPWeinerLMMonoclonal antibody therapy of cancerNat Biotechnol20052391147115716151408
- WuAMSenterPDArming antibodies: prospects and challenges for immunoconjugatesNat Biotechnol20052391137114616151407
- JhaRKMaQChenSShaHDingSRelationship of fibronectin and CD44v6 expression with invasive growth and metastasis of liver cancerCancer Invest200927332432819194823
- SunHLiuGTInhibitory effect of anti-hepatitis drug bicyclol on invasion of human hepatocellular carcinoma MHCC97-H cells with high metastasis potential and its relative mechanismsJ Asian Nat Prod Res200911657658320183293
- Garmy-SudiniBAvraamidesCJSchmidMCIntegrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasisCancer Res20107083042305120388801
- JanikMELitynskaAVereeckenPCell migration – the role of integrin glycosylation DBiochim Biophys Acta20101800654555520332015
- KruegelJMiosgeNBasement membrane components are key players in specialized extracellular matricesCell Mol Life Sci201067172879289520428923
- WiradjajaFDiTommasoTSmythIBasement membranes in development and diseaseBirth Defects Res C Embryo Today201090183120301220
- EscaffSFernándezJMGonzálezLOStudy of matrix metalloproteinases and their inhibitors in prostate cancerBr J Cancer2010102592292920160732